Pulmonary delivery of inhalable nanoparticles: dry powder inhalers
about
Dry Powder Inhalers: A Focus on Advancements in Novel Drug Delivery SystemsDry powder inhalers in COPD, lung inflammation and pulmonary infections.Inhalable nanocomposite microparticles: preparation, characterization and factors affecting formulation.Distribution of effervescent inhalable nanoparticles after pulmonary delivery: anin vivostudy
P2860
Pulmonary delivery of inhalable nanoparticles: dry powder inhalers
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2011
@uk
name
Pulmonary delivery of inhalable nanoparticles: dry powder inhalers
@en
Pulmonary delivery of inhalable nanoparticles: dry powder inhalers
@nl
type
label
Pulmonary delivery of inhalable nanoparticles: dry powder inhalers
@en
Pulmonary delivery of inhalable nanoparticles: dry powder inhalers
@nl
prefLabel
Pulmonary delivery of inhalable nanoparticles: dry powder inhalers
@en
Pulmonary delivery of inhalable nanoparticles: dry powder inhalers
@nl
P2093
P2860
P356
P1433
P1476
Pulmonary delivery of inhalable nanoparticles: dry powder inhalers
@en
P2093
MHD Kamal Al-Hallak
Muhammad Khan Sarfraz
Raimar Löbenberg
Shirzad Azarmi
Warren H Finlay
Wilson H Roa
P2860
P304
P356
10.4155/TDE.11.100
P577
2011-10-01T00:00:00Z